Literature DB >> 10050013

Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets.

B Aring;kesson1, I Lundquist.   

Abstract

1. We have investigated, with a combined in vitro and in vivo approach, the influence on insulin and glucagon release stimulated by the cholinergic, muscarinic agonist carbachol of different NO modulators, i.e. the nitric oxide synthase (NOS) inhibitors NG-nitro-L-arginine methyl ester (L-NAME), NG-monomethyl-L-arginine (L-NMMA) and 7-nitroindazole as well as the intracellular NO donor hydroxylamine. 2. At basal glucose (7 mM) carbachol dose-dependently stimulated insulin release from isolated islets with a half-maximal response at approximately 1 microM of the agonist. In the presence of 5 mM L-NAME (a concentration that did not influence basal insulin release) the insulin response was markedly increased along the whole dose-response curve and the threshold for carbachol stimulation was significantly lowered. 3. Carbachol-stimulated islets displayed an increased insulin release and a suppressed glucagon release in the presence of L-NAME, L-NMMA or 7-nitroindazole. Significant suppression of glucagon release (except for L-NAME) was achieved at lower concentrations (approximately 0.1-0.5 mM) of the NOS inhibitors than the potentiation of insulin release (1.0-5.0 mM). The intracellular NO donor hydroxylamine dose-dependently inhibited carbachol-induced insulin release but stimulated glucagon release only at a low concentration (3 microM). 4. In islets depolarized with 30 mM K+ in the presence of the KATP channel opener diazoxide, NOS inhibition by 5 mM L-NAME still markedly potentiated carbachol-induced insulin release (although less so than in normal islets) and suppressed glucagon release. 5. In vivo pretreatment of mice with L-NAME was followed by a markedly increased insulin release and a reduced glucagon release in response to an i.v. injection of carbachol. 6. The data suggest that NO is a negative modulator of insulin release but a positive modulator of glucagon release induced by cholinergic muscarinic stimulation. These effects were also evident in K+ depolarized islets and thus NO might exert a major influence on islet hormone secretion independently of membrane depolarization events.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10050013      PMCID: PMC2269164          DOI: 10.1111/j.1469-7793.1999.463ac.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  35 in total

Review 1.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 2.  Control of insulin secretion: a model involving Ca2+, cAMP and diacylglycerol.

Authors:  W S Zawalich; H Rasmussen
Journal:  Mol Cell Endocrinol       Date:  1990-04-17       Impact factor: 4.102

3.  An improved method for isolation of mouse pancreatic islets.

Authors:  M Gotoh; T Maki; T Kiyoizumi; S Satomi; A P Monaco
Journal:  Transplantation       Date:  1985-10       Impact factor: 4.939

Review 4.  Thiols and pancreatic beta-cell function: a review.

Authors:  H P Ammon; M Mark
Journal:  Cell Biochem Funct       Date:  1985-07       Impact factor: 3.685

Review 5.  Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the Islets of Langerhans.

Authors:  R E Miller
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

6.  L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase.

Authors:  S G Laychock; M E Modica; C T Cavanaugh
Journal:  Endocrinology       Date:  1991-12       Impact factor: 4.736

7.  Glucagon immunoreactivity in plasma from normal and dystrophic mice.

Authors:  B Ahrén; I Lundquist
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

8.  Blood glucose level in mice. 1. Evaluation of a new technique of multiple serial sampling.

Authors:  C Rerup; I Lundquist
Journal:  Acta Endocrinol (Copenh)       Date:  1966-07

9.  Signal transduction in islet hormone release: interaction of nitric oxide with basal and nutrient-induced hormone responses.

Authors:  A Salehi; F Parandeh; I Lundquist
Journal:  Cell Signal       Date:  1998-10       Impact factor: 4.315

10.  Effect of L-dopa administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse.

Authors:  I Lundquist; G Panagiotidis; A Stenström
Journal:  Pancreas       Date:  1991-09       Impact factor: 3.327

View more
  5 in total

1.  Total parenteral nutrition modulates hormone release by stimulating expression and activity of inducible nitric oxide synthase in rat pancreatic islets.

Authors:  A Salehi; M Ekelund; R Henningsson; I Lundquist
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

2.  Nitric oxide and hydroperoxide affect islet hormone release and Ca(2+) efflux.

Authors:  B Akesson; I Lundquist
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

3.  Cyclic GMP kinase I modulates glucagon release from pancreatic α-cells.

Authors:  Veronika Leiss; Andreas Friebe; Andrea Welling; Franz Hofmann; Robert Lukowski
Journal:  Diabetes       Date:  2010-10-26       Impact factor: 9.461

4.  The effect of nitric oxide inhibitors and Snitroso-Nacetylpenicillamine on glucose concentration in an animal model.

Authors:  Sophia Bryan; Ruby Alexander-Lindo; Tara Dasgupta; Donovan McGrowder
Journal:  J Nat Sci Biol Med       Date:  2011-01

5.  Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.

Authors:  Albert Salehi; Sandra Meidute Abaraviciene; Javier Jimenez-Feltstrom; Claes-Göran Ostenson; Suad Efendic; Ingmar Lundquist
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.